A novel SMARCC1 BAFopathy implicates neural progenitor epigenetic dysregulation in human hydrocephalus
Brain · 2024
DOI: 10.1093/brain/awad405 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain, 2024. Verfasst von Amrita K Singh und 29 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Yale University, New Haven, CT 06510, USA. Hauptthemen laut MEDLINE: Autism Spectrum Disorder, Hydrocephalus, Genetic Diseases, X-Linked. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 111 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, NICHD NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
Hydrocephalus, characterized by cerebral ventriculomegaly, is the most common disorder requiring brain surgery in children. Recent studies have implicated SMARCC1, a component of the BRG1-associated factor (BAF) chromatin remodelling complex, as a candidate congenital hydrocephalus gene. However, SMARCC1 variants have not been systematically examined in a large patient cohort or conclusively linked with a human syndrome. Moreover, congenital hydrocephalus-associated SMARCC1 variants have not been functionally validated or mechanistically studied in vivo. Here, we aimed to assess the prevalence of SMARCC1 variants in an expanded patient cohort, describe associated clinical and radiographic phenotypes, and assess the impact of Smarcc1 depletion in a novel Xenopus tropicalis model of congenital hydrocephalus. To do this, we performed a genetic association study using whole-exome sequencing from a cohort consisting of 2697 total ventriculomegalic trios, including patients with neurosurgically-treated congenital hydrocephalus, that total 8091 exomes collected over 7 years (2016–23). A comparison control cohort consisted of 1798 exomes from unaffected siblings of patients with autism spectrum disorder and their unaffected parents were sourced from the Simons Simplex Collection. Enrichment and impact on protein structure were assessed in identified variants. Effects on the human fetal brain transcriptome were examined with RNA-sequencing and Smarcc1 knockdowns were generated in Xenopus and studied using optical coherence tomography imaging, in situ hybridization and immunofluorescence. SMARCC1 surpassed genome-wide significance thresholds, yielding six rare, protein-altering de novo variants localized to highly conserved residues in key functional domains. Patients exhibited hydrocephalus with aqueductal stenosis; corpus callosum abnormalities, developmental delay, and cardiac defects were also common. Xenopus knockdowns recapitulated both aqueductal stenosis and cardiac defects and were rescued by wild-type but not patient-specific variant SMARCC1. Hydrocephalic SMARCC1-variant human fetal brain and Smarcc1-variant Xenopus brain exhibited a similarly altered expression of key genes linked to midgestational neurogenesis, including the transcription factors NEUROD2 and MAB21L2. These results suggest de novo variants in SMARCC1 cause a novel human BAFopathy we term ‘SMARCC1-associated developmental dysgenesis syndrome’, characterized by variable presence of cerebral ventriculomegaly, aqueductal stenosis, developmental delay and a variety of structural brain or cardiac defects. These data underscore the importance of SMARCC1 and the BAF chromatin remodelling complex for human brain morphogenesis and provide evidence for a ‘neural stem cell’ paradigm of congenital hydrocephalus pathogenesis. These results highlight utility of trio-based whole-exome sequencing for identifying pathogenic variants in sporadic congenital structural brain disorders and suggest whole-exome sequencing may be a valuable adjunct in clinical management of congenital hydrocephalus patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, Yale University, New Haven, CT 06510, USA.
- Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02115, USA.
- Department of Genetics, Yale University, New Haven, CT 06510, USA.
- Department of Pediatrics, Yale University, New Haven, CT 06510, USA.
- GeneDx, Gaithersburg, MD 20877, USA.
- Department of Neuroscience, Yale University, New Haven, CT 06510, USA.
ORCID-Profile: Garrett Allington, Shozeb Haider, Sheng Chih Jin, Engin Deniz, Kristopher T Kahle
Förderung
- NINDS NIH HHS
- NICHD NIH HHS
- NHLBI NIH HHS
- NHGRI NIH HHS
- NIH HHS
- Yale-NIH Center for Mendelian Genomics
- University of Washington Center for Mendelian Genomics
- National Institutes of Health
Zitieren
APA
Singh, A. K., Allington, G., Viviano, S., McGee, S., Kiziltug, E., Ma, S., Zhao, S., Mekbib, K. Y., Shohfi, J. P., Duy, P. Q., DeSpenza, T., Furey, C. G., Reeves, B. C., Smith, H., Sousa, A. M. M., Cherskov, A., Allocco, A., Nelson-Williams, C., Haider, S., …, & Kahle, K. T. (2024). A novel SMARCC1 BAFopathy implicates neural progenitor epigenetic dysregulation in human hydrocephalus. Brain. https://doi.org/10.1093/brain/awad405
Vancouver
Singh AK, Allington G, Viviano S, McGee S, Kiziltug E, Ma S, et al. A novel SMARCC1 BAFopathy implicates neural progenitor epigenetic dysregulation in human hydrocephalus. Brain. 2024. doi:10.1093/brain/awad405
BibTeX
@article{Singh2024,
author = {Singh, Amrita K and Allington, Garrett and Viviano, Stephen and McGee, Stephen and Kiziltug, Emre and Ma, Shaojie and Zhao, Shujuan and Mekbib, Kedous Y and Shohfi, John P and Duy, Phan Q and DeSpenza, Tyrone and Furey, Charuta G and Reeves, Benjamin C and Smith, Hannah and Sousa, André M M and Cherskov, Adriana and Allocco, August and Nelson-Williams, Carol and Haider, Shozeb and Rizvi, Syed R A and Alper, Seth L and Sestan, Nenad and Shimelis, Hermela and Walsh, Lauren K and Lifton, Richard P and Moreno-De-Luca, Andres and Jin, Sheng Chih and Kruszka, Paul and Deniz, Engin and Kahle, Kristopher T},
title = {A novel SMARCC1 BAFopathy implicates neural progenitor epigenetic dysregulation in human hydrocephalus},
journal = {Brain},
year = {2024},
doi = {10.1093/brain/awad405}
}
EUVIMED